Recent Finacing
Recent Raise
RefleXion develops and commercializes biology-guided radiotherapy using PET radiotracers to continuously localize tumors and synchronize with a linear accelerator via the RefleXion X1 platform, enabling SBRT, SRS, and IMRT.
